Dangers of sibutramine consumption as an appetite suppressant
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/20802 |
Resumo: | Introduction: Sibutramine is a drug used to treat obesity, a drug with a black stripe, because of the way it acts on the brain and acts quickly increasing the feeling of satiety Consumed most often by women in search of the perfect body. Objective: The aim of the study was to analyze the dangers of sibutramine in weight loss and the effects that occur in the body. Material and Methods: The study was conducted through a literature review and aims to explain the dangers that occur when this drug is consumed incorrectly, inhibiting the appetite for weight loss. Articles with a time limit from 2015 to 2021 were selected. The study took place from February to July 2021, in the databases of the Virtual Health Library (VHL), the Latin American and Caribbean Literature on Health Sciences (LILACS) and in Scientific Electronic Library Online (SciELO). Results and discussion: Sibutramine is an approved medicine and is widely consumed by people, where they feel satiated and lose weight very fast, due to decreased appetite and fat burning. The drug has proven efficacy in weight loss and inadequate consumption, with the lack of healthy eating and physical activity, they present dangers to human health with several adverse effects. Conclusion: The percentage of people who consume sibutramine has grown in recent years, all due to rapid weight loss caused by overweight and obesity. Misuse causes many serious adverse effects. Therefore, before self-medicating, the patient must see a doctor to start the weight loss treatment. |
id |
UNIFEI_a48fb4a5c3a00e0cecb0f51b25ad72d9 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/20802 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Dangers of sibutramine consumption as an appetite suppressantPeligros del consumo de sibutramina como supresor del apetitoPerigos do consumo da sibutramina como inibidora de apetiteConsumptionHazardsInhibitorSibutramine.ConsumoRiesgosInhibidorSibutramina.ConsumoPerigosInibidorSibutramina. Introduction: Sibutramine is a drug used to treat obesity, a drug with a black stripe, because of the way it acts on the brain and acts quickly increasing the feeling of satiety Consumed most often by women in search of the perfect body. Objective: The aim of the study was to analyze the dangers of sibutramine in weight loss and the effects that occur in the body. Material and Methods: The study was conducted through a literature review and aims to explain the dangers that occur when this drug is consumed incorrectly, inhibiting the appetite for weight loss. Articles with a time limit from 2015 to 2021 were selected. The study took place from February to July 2021, in the databases of the Virtual Health Library (VHL), the Latin American and Caribbean Literature on Health Sciences (LILACS) and in Scientific Electronic Library Online (SciELO). Results and discussion: Sibutramine is an approved medicine and is widely consumed by people, where they feel satiated and lose weight very fast, due to decreased appetite and fat burning. The drug has proven efficacy in weight loss and inadequate consumption, with the lack of healthy eating and physical activity, they present dangers to human health with several adverse effects. Conclusion: The percentage of people who consume sibutramine has grown in recent years, all due to rapid weight loss caused by overweight and obesity. Misuse causes many serious adverse effects. Therefore, before self-medicating, the patient must see a doctor to start the weight loss treatment.Introducción: La sibutramina es un fármaco que se utiliza para tratar la obesidad, un fármaco con una raya negra, por la forma en que actúa sobre el cerebro y actúa rápidamente aumentando la sensación de saciedad. Consumido con mayor frecuencia por mujeres en busca del cuerpo perfecto. Objetivo: El objetivo del estudio fue analizar los peligros de la sibutramina en la pérdida de peso y los efectos que se producen en el organismo. Material y métodos: El estudio se realizó a través de una revisión de la literatura y tiene como objetivo explicar los peligros que se producen cuando este fármaco se consume de forma incorrecta, inhibiendo el apetito por adelgazar. Se seleccionaron artículos con plazo de 2015 a 2021. El estudio se llevó a cabo de febrero a julio de 2021, en las bases de datos de la Biblioteca Virtual en Salud (BVS), la Literatura Latinoamericana y del Caribe en Ciencias de la Salud (LILACS) y en Electrónica Científica. Biblioteca en línea (SciELO). Resultados y discusión: La sibutramina es un medicamento aprobado y es ampliamente consumido por personas, donde se sienten saciadas y pierden peso muy rápido, debido a la disminución del apetito y la quema de grasa. El fármaco ha demostrado su eficacia en la pérdida de peso y su consumo inadecuado, siendo la falta de una alimentación saludable y de actividad física peligros para la salud humana con varios efectos adversos. Conclusión: El porcentaje de personas que consumen sibutramina ha crecido en los últimos años, todo debido a la rápida pérdida de peso provocada por el sobrepeso y la obesidad. El mal uso causa muchos efectos adversos graves. Por tanto, antes de automedicarse, el paciente debe acudir al médico para iniciar el tratamiento de adelgazamiento.Introdução: A sibutramina é um medicamento usado para tratar a obesidade, um fármaco de tarja preta, pelo modo como atua no cérebro e atua aumentando rapidamente a sensação de saciedade Consumido na maioria das vezes pelas mulheres na busca pelo corpo perfeito. Objetivo: O objetivo do estudo foi analisar os perigos da sibutramina na perda de peso e os efeitos que ocorrem no organismo. Material e Métodos: O estudo foi conduzido por meio de uma pesquisa bibliográfica e tem como proposta explanar sobre os perigos que ocorrem quando este medicamento é consumido de forma incorreta inibindo o apetite para a perda de peso. Foram selecionados artigos com limite temporal de 2015 a 2021. O estudo ocorreu de fevereiro a julho de 2021, nas bases de dados da Biblioteca Virtual em Saúde (BVS), da Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS) e no Scientific Eletronic Library Online (SciELO). Resultados e discussão: A sibutramina é um remédio aprovado e muito consumido pelas pessoas, onde se sentem saciados e perdem peso muito rápido, devido a diminuição do apetite e a queima de gordura. O fármaco tem eficácia comprovada no emagrecimento e o consumo inadequado, com a falta de uma alimentação saudável e atividade física apresentam perigos a saúde do ser humano com vários efeitos adversos. Conclusão: O percentual de pessoas que consomem a sibutramina cresceu nos últimas anos, tudo isso pelo emagrecimento rápido causados pelo sobrepeso e obesidade. O uso incorreto provoca muitos efeitos adversos graves. Portanto, antes de se automedicar, o paciente deve procurar um médico para começar o tratamento na perda de peso.Research, Society and Development2021-10-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2080210.33448/rsd-v10i13.20802Research, Society and Development; Vol. 10 No. 13; e156101320802Research, Society and Development; Vol. 10 Núm. 13; e156101320802Research, Society and Development; v. 10 n. 13; e1561013208022525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/20802/18771Copyright (c) 2021 Márcio Gomes da Silva; Thalysson Pereira Rosa; Yolanda de Jesus Moraishttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Márcio Gomes da Rosa, Thalysson Pereira Morais, Yolanda de Jesus 2021-11-21T18:26:28Zoai:ojs.pkp.sfu.ca:article/20802Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:40:20.665832Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Dangers of sibutramine consumption as an appetite suppressant Peligros del consumo de sibutramina como supresor del apetito Perigos do consumo da sibutramina como inibidora de apetite |
title |
Dangers of sibutramine consumption as an appetite suppressant |
spellingShingle |
Dangers of sibutramine consumption as an appetite suppressant Silva, Márcio Gomes da Consumption Hazards Inhibitor Sibutramine. Consumo Riesgos Inhibidor Sibutramina. Consumo Perigos Inibidor Sibutramina. |
title_short |
Dangers of sibutramine consumption as an appetite suppressant |
title_full |
Dangers of sibutramine consumption as an appetite suppressant |
title_fullStr |
Dangers of sibutramine consumption as an appetite suppressant |
title_full_unstemmed |
Dangers of sibutramine consumption as an appetite suppressant |
title_sort |
Dangers of sibutramine consumption as an appetite suppressant |
author |
Silva, Márcio Gomes da |
author_facet |
Silva, Márcio Gomes da Rosa, Thalysson Pereira Morais, Yolanda de Jesus |
author_role |
author |
author2 |
Rosa, Thalysson Pereira Morais, Yolanda de Jesus |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Silva, Márcio Gomes da Rosa, Thalysson Pereira Morais, Yolanda de Jesus |
dc.subject.por.fl_str_mv |
Consumption Hazards Inhibitor Sibutramine. Consumo Riesgos Inhibidor Sibutramina. Consumo Perigos Inibidor Sibutramina. |
topic |
Consumption Hazards Inhibitor Sibutramine. Consumo Riesgos Inhibidor Sibutramina. Consumo Perigos Inibidor Sibutramina. |
description |
Introduction: Sibutramine is a drug used to treat obesity, a drug with a black stripe, because of the way it acts on the brain and acts quickly increasing the feeling of satiety Consumed most often by women in search of the perfect body. Objective: The aim of the study was to analyze the dangers of sibutramine in weight loss and the effects that occur in the body. Material and Methods: The study was conducted through a literature review and aims to explain the dangers that occur when this drug is consumed incorrectly, inhibiting the appetite for weight loss. Articles with a time limit from 2015 to 2021 were selected. The study took place from February to July 2021, in the databases of the Virtual Health Library (VHL), the Latin American and Caribbean Literature on Health Sciences (LILACS) and in Scientific Electronic Library Online (SciELO). Results and discussion: Sibutramine is an approved medicine and is widely consumed by people, where they feel satiated and lose weight very fast, due to decreased appetite and fat burning. The drug has proven efficacy in weight loss and inadequate consumption, with the lack of healthy eating and physical activity, they present dangers to human health with several adverse effects. Conclusion: The percentage of people who consume sibutramine has grown in recent years, all due to rapid weight loss caused by overweight and obesity. Misuse causes many serious adverse effects. Therefore, before self-medicating, the patient must see a doctor to start the weight loss treatment. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-10-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/20802 10.33448/rsd-v10i13.20802 |
url |
https://rsdjournal.org/index.php/rsd/article/view/20802 |
identifier_str_mv |
10.33448/rsd-v10i13.20802 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/20802/18771 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Márcio Gomes da Silva; Thalysson Pereira Rosa; Yolanda de Jesus Morais https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Márcio Gomes da Silva; Thalysson Pereira Rosa; Yolanda de Jesus Morais https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 13; e156101320802 Research, Society and Development; Vol. 10 Núm. 13; e156101320802 Research, Society and Development; v. 10 n. 13; e156101320802 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052789199732736 |